These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4327021)

  • 1. Synthesis of (5-valine,7-N-methylalanine)-angiotensin II, a hypertensive peptide.
    Andreatta RH; Scheraga HA
    J Med Chem; 1971 Jun; 14(6):489-92. PubMed ID: 4327021
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkylating analogs of peptide hormones. 2. Synthesis and properties of p-(N,N-bis(2-chloroethyl)amino)phenylbutyryl derivatives of angiotensin II.
    Paiva TB; Paiva AC; Freer RJ; Stewart JM
    J Med Chem; 1972 Jan; 15(1):6-8. PubMed ID: 4331919
    [No Abstract]   [Full Text] [Related]  

  • 3. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
    Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
    J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
    [No Abstract]   [Full Text] [Related]  

  • 4. Alkylating analogs of peptide hormones. 1. Synthesis and properties of p-(N,N-)-bis(2-chloroethyl)amino)phenylbutyryl derivatives of bradykinin and bradykinin potentiating factor.
    Freer RJ; Stewart JM
    J Med Chem; 1972 Jan; 15(1):1-5. PubMed ID: 4331917
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
    Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
    [No Abstract]   [Full Text] [Related]  

  • 6. Analogs of angiotensin II. II. Mechanism of receptor interaction.
    Khairallah PA; Toth A; Bumpus FM
    J Med Chem; 1970 Mar; 13(2):181-4. PubMed ID: 4313898
    [No Abstract]   [Full Text] [Related]  

  • 7. A new class of angiotensin inhibitors: N-methylphenylalanine analogs.
    Peña C; Stewart JM; Goodfriend TC
    Life Sci; 1974 Apr; 14(7):1331-6. PubMed ID: 4363010
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
    Paiva AC; Nouailhetas VL; Paiva TB
    J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II analogs. 11. Further studies on des-aspartyl-angiotensin II.
    Jorgensen EC; Kiraly-Olah IC; Lee TC; Windridge GC
    J Med Chem; 1974 Mar; 17(3):323-6. PubMed ID: 4359545
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
    Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
    J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin II. Synthesis and biological activity of 6-(1-methylhistidine) and 6-(3-methylhistidine) analogs.
    Needleman P; Marshall GR; Rivier J
    J Med Chem; 1973 Sep; 16(9):968-70. PubMed ID: 4355510
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
    Schoelkens BA; Wissmann H; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on lidoflazine (R-7904).
    Türker RK; Kayaalp SO; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1209-12. PubMed ID: 4387885
    [No Abstract]   [Full Text] [Related]  

  • 14. Some aspects of the pharmacology of valyl-beta-(pyrazolyl-3)-L-alanyl6-angiotensin II.
    Hageman WE; Hofmann K; Ertel RJ; Buckley JP
    J Pharmacol Exp Ther; 1969 Aug; 168(2):295-302. PubMed ID: 4308499
    [No Abstract]   [Full Text] [Related]  

  • 15. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.
    Stewart JM; Ferreira SH; Greene LJ
    Biochem Pharmacol; 1971 Jul; 20(7):1557-67. PubMed ID: 4355304
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of lipophilic character on the biological activity of synthetic angiotensin peptides.
    Nouailhetas VL; Nakaie CR; Juliano L; Paiva AC
    Biochem J; 1977 Sep; 165(3):547-51. PubMed ID: 921765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II analogs. II. Cyclo-(-Val-Tyr-Ile-His-Pro-Phe-).
    Jorgensen EC; Patton W
    J Med Chem; 1969 Sep; 12(5):935-6. PubMed ID: 4309508
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of a proposed pepsitensin.
    Paiva AC; Paiva TB; Miyamoto ME
    J Med Chem; 1973 Mar; 16(3):280-1. PubMed ID: 4738981
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of pH on tachyphylaxis to angiotensin peptides in the isolated guinea pig ileum and rat uterus.
    Paiva TB; Juliano L; Nouailhetas VL; Paiva AC
    Eur J Pharmacol; 1974 Feb; 25(2):191-6. PubMed ID: 4373250
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological activity of angiotensin-II modified by tyrosine sulfation.
    Hagiwara M; Ohuchi E; Hongo K; Oki M; Wada K; Morikawa T; Kobashi K
    Jpn J Pharmacol; 1990 Mar; 52(3):493-5. PubMed ID: 2332941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.